For instance, in hepatocellular carcinoma (HCC), CD133+ cells promote the M2 polarisation of TAMs by the release of IL-8 which in turn is responsible for the therapeutic resistance [155, 156]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.